Kostas Syrigos

4.6k total citations
114 papers, 3.3k citations indexed

About

Kostas Syrigos is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Molecular Biology. According to data from OpenAlex, Kostas Syrigos has authored 114 papers receiving a total of 3.3k indexed citations (citations by other indexed papers that have themselves been cited), including 74 papers in Oncology, 57 papers in Pulmonary and Respiratory Medicine and 25 papers in Molecular Biology. Recurrent topics in Kostas Syrigos's work include Lung Cancer Treatments and Mutations (31 papers), Pancreatic and Hepatic Oncology Research (25 papers) and Colorectal Cancer Treatments and Studies (21 papers). Kostas Syrigos is often cited by papers focused on Lung Cancer Treatments and Mutations (31 papers), Pancreatic and Hepatic Oncology Research (25 papers) and Colorectal Cancer Treatments and Studies (21 papers). Kostas Syrigos collaborates with scholars based in Greece, United States and United Kingdom. Kostas Syrigos's co-authors include Muhammad Wasif Saif, Nektaria Makrilia, Eleni Karapanagiotou, Georgios S. Papaetis, Leonidas Manolopoulos, Alexios S Strimpakos, Αναστάσιος Κόλλιας, Anastasios Dimou, Kevin J. Harrington and Muhammad Wasif Saif and has published in prestigious journals such as Journal of Clinical Oncology, Cancer and Clinical Cancer Research.

In The Last Decade

Kostas Syrigos

111 papers receiving 3.2k citations

Peers

Kostas Syrigos
Adnan Ghafoor United States
Gaetano Facchini Italy
Yasutsuna Sasaki Japan
Kazuhiro Yanagihara Japan
Winston Tan United States
Catherine C. Lerro United States
Miguel Izquierdo Spain
Shiying Yu China
Jin S. Lee United States
Peter J. Van Veldhuizen United States
Adnan Ghafoor United States
Kostas Syrigos
Citations per year, relative to Kostas Syrigos Kostas Syrigos (= 1×) peers Adnan Ghafoor

Countries citing papers authored by Kostas Syrigos

Since Specialization
Citations

This map shows the geographic impact of Kostas Syrigos's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kostas Syrigos with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kostas Syrigos more than expected).

Fields of papers citing papers by Kostas Syrigos

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kostas Syrigos. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kostas Syrigos. The network helps show where Kostas Syrigos may publish in the future.

Co-authorship network of co-authors of Kostas Syrigos

This figure shows the co-authorship network connecting the top 25 collaborators of Kostas Syrigos. A scholar is included among the top collaborators of Kostas Syrigos based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kostas Syrigos. Kostas Syrigos is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Sampsonas, Fotios, Ουρανία Παπαϊωάννου, Vassiliki Tzelepi, et al.. (2025). Geographical Inequalities and Comorbidities in the Timely Diagnosis of NSCLC: A Real-Life Retrospective Study from a Tertiary Hospital in Western Greece. Cancers. 17(16). 2701–2701. 1 indexed citations
2.
Datar, Ila, Sacha C. Hauc, Shruti Desai, et al.. (2021). Spatial Analysis and Clinical Significance of HLA Class-I and Class-II Subunit Expression in Non–Small Cell Lung Cancer. Clinical Cancer Research. 27(10). 2837–2847. 26 indexed citations
3.
Gerotziafas, Grigoris, Isabelle Mahé, Eleftheria Lefkou, et al.. (2020). Overview of risk assessment models for venous thromboembolism in ambulatory patients with cancer. Thrombosis Research. 191. S50–S57. 16 indexed citations
4.
Gage, Julia C., Pere Gascón, Rajnish Nagarkar, et al.. (2017). P2.06-033 Long-Term Safety and Efficacy of Darbepoetin Alfa in Subjects with Advanced Stage NSCLC Receiving Multi-Cycle Chemotherapy. Journal of Thoracic Oncology. 12(1). S1091–S1092. 1 indexed citations
5.
6.
Saif, Muhammad Wasif, et al.. (2014). Maintenance therapy with capecitabine in patients with locally advanced unresectable pancreatic adenocarcinoma. Oncology Letters. 8(3). 1302–1306. 6 indexed citations
7.
Charpidou, Andriani, et al.. (2014). Wedge resection and segmentectomy in patients with stage I non-small cell lung carcinoma. Oncology Reviews. 8(2). 234–234. 17 indexed citations
8.
Schmid‐Bindert, Gerald, Vittorio Gebbia, Frank Mayer, et al.. (2013). Phase II study of pemetrexed and cisplatin plus cetuximab followed by pemetrexed and cetuximab maintenance therapy in patients with advanced nonsquamous non-small cell lung cancer. Lung Cancer. 81(3). 428–434. 8 indexed citations
9.
10.
Makrilia, Nektaria, Maria Ralli, Christina Alamara, et al.. (2010). Phase II Study of Gemcitabine Plus Docetaxel as Second-Line Treatment in Malignant Pleural Mesothelioma. American Journal of Clinical Oncology. 34(1). 38–42. 20 indexed citations
11.
Karapanagiotou, Eleni, et al.. (2009). Molecular Prognostic and Predictive Markers in Lung Cancer. 2(1). 1 indexed citations
12.
Karapanagiotou, Eleni, et al.. (2009). Carboplatin-pemetrexed adjuvant chemotherapy in resected non-small cell lung cancer (NSCLC): a phase II study.. PubMed. 29(10). 4297–301. 13 indexed citations
13.
Malamos, Nikolaos, Ioannis Boukovinas, Nikolaos Ziras, et al.. (2009). FEC versus sequential docetaxel followed by epirubicin/cyclophosphamide as adjuvant chemotherapy in women with axillary node-positive early breast cancer: a randomized study of the Hellenic Oncology Research Group (HORG). Breast Cancer Research and Treatment. 119(1). 95–104. 34 indexed citations
14.
Dimou, Anastasios, Kostas Syrigos, & Muhammad Wasif Saif. (2009). Disparities in colorectal cancer in African-Americans vs Whites: Before and after diagnosis. World Journal of Gastroenterology. 15(30). 3734–3734. 117 indexed citations
15.
Syrigou, Ekaterini, et al.. (2009). Hypersensitivity Reactions to Oxaliplatin: A Retrospective Study and the Development of a Desensitization Protocol. Clinical Colorectal Cancer. 8(2). 106–109. 31 indexed citations
16.
Papaetis, Georgios S. & Kostas Syrigos. (2009). Sunitinib. BioDrugs. 23(6). 377–389. 175 indexed citations
17.
Syrigou, Ekaterini, et al.. (2008). Hypersensitivity reactions to antineoplastic agents: an overview. Anti-Cancer Drugs. 20(1). 1–6. 39 indexed citations
18.
Charpidou, Andriani, et al.. (2007). P2-243: A Phase II study of Carboplatin plus Pemetrexed in previously treated patients with non-small cell lung cancer (NSCLC). Journal of Thoracic Oncology. 2(8). S669–S669. 1 indexed citations
19.
Androulakis, Nikolaos, Gerasimos Aravantinos, Kostas Syrigos, et al.. (2006). Oxaliplatin as First-Line Treatment in Inoperable Biliary Tract Carcinoma. Oncology. 70(4). 280–284. 20 indexed citations
20.
Syrigos, Kostas, et al.. (1989). Paradoxical Growth Hormone Response following Thyroid-Stimulating Hormone Administration in the Polycystic Ovary Syndrome. Hormone Research. 31(3). 119–124. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Adnan Ghafoor Breakdown of academic impact, for papers by Gaetano Facchini Breakdown of academic impact, for papers by Yasutsuna Sasaki Breakdown of academic impact, for papers by Kazuhiro Yanagihara Breakdown of academic impact, for papers by Winston Tan Breakdown of academic impact, for papers by Catherine C. Lerro Breakdown of academic impact, for papers by Miguel Izquierdo Breakdown of academic impact, for papers by Shiying Yu Breakdown of academic impact, for papers by Jin S. Lee Breakdown of academic impact, for papers by Peter J. Van Veldhuizen
Rankless by CCL
2026